Thyroid Peroxidase Deficiency and Total Iodide Organification Defect

Laura Fugazzola

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The iodination of tyrosine residues or iodide organification, is catalyzed by the thyroperoxidase (TPO). TPO is a membrane-bound hemoprotein located at the apical membrane of the thyroid cell. Besides the binding of iodine to tyrosine, TPO also catalyzes the coupling of iodotyrosines to iodothyronine residues in thyroglobulin (Tg) under oxidative conditions. The human TPO gene, which localizes on chromosome 2p25, is divided into 17 exons and covers approximately 150 kilobases (kb) of DNA. Differently sized TPO mRNAs have been recognized in thyroid cells. TPO defects are among the most-frequent cause of inborn abnormalities of thyroid hormone synthesis. Nearly 50 different mutations have been described, mostly single nucleotide substitutions and, in the minority, small deletions/insertions or splicing site mutations. Patients harboring TPO mutations, in compound heterozygosity or homozygosity, present with a TIOD, due to the impaired TPO function, resulting in CH. According to the recessive mode of inheritance, affected subjects are homozygous or compound heterozygous for gene mutations. However, about 20% of the reported families with a TIOD phenotype harbor a single TPO mutated allele. The explanation for TIOD in these single heterozygous cases is presently unknown, except for three cases. The etiological diagnosis of CH, including dyshormonogenic defects due to TPO mutations, is based on clinical examination, biochemical tests, thyroid ultrasound and scintigraphy with KClO4 discharge test. Finally, the severe hypothyroidism resulting from TPO mutations should be promptly treated with the thyroid hormone, in order to maintain TSH levels at the lower limit of the normal range.

Original languageEnglish
Title of host publicationComprehensive Handbook of Iodine
PublisherElsevier Inc.
Pages539-547
Number of pages9
ISBN (Print)9780123741356
DOIs
Publication statusPublished - 2009

Fingerprint

iodide peroxidase
Iodides
iodides
Mutation
Thyroid Gland
mutation
Thyroid Hormones
Tyrosine
Monoiodotyrosine
Thyroglobulin
thyroid hormones
Halogenation
Hypothyroidism
tyrosine
Radionuclide Imaging
Iodine
Genes
Thyroid Dyshormonogenesis 2A
Exons
Reference Values

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)

Cite this

Fugazzola, L. (2009). Thyroid Peroxidase Deficiency and Total Iodide Organification Defect. In Comprehensive Handbook of Iodine (pp. 539-547). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374135-6.00056-X

Thyroid Peroxidase Deficiency and Total Iodide Organification Defect. / Fugazzola, Laura.

Comprehensive Handbook of Iodine. Elsevier Inc., 2009. p. 539-547.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fugazzola, L 2009, Thyroid Peroxidase Deficiency and Total Iodide Organification Defect. in Comprehensive Handbook of Iodine. Elsevier Inc., pp. 539-547. https://doi.org/10.1016/B978-0-12-374135-6.00056-X
Fugazzola L. Thyroid Peroxidase Deficiency and Total Iodide Organification Defect. In Comprehensive Handbook of Iodine. Elsevier Inc. 2009. p. 539-547 https://doi.org/10.1016/B978-0-12-374135-6.00056-X
Fugazzola, Laura. / Thyroid Peroxidase Deficiency and Total Iodide Organification Defect. Comprehensive Handbook of Iodine. Elsevier Inc., 2009. pp. 539-547
@inbook{2429501115704debb27e122e4ca85440,
title = "Thyroid Peroxidase Deficiency and Total Iodide Organification Defect",
abstract = "The iodination of tyrosine residues or iodide organification, is catalyzed by the thyroperoxidase (TPO). TPO is a membrane-bound hemoprotein located at the apical membrane of the thyroid cell. Besides the binding of iodine to tyrosine, TPO also catalyzes the coupling of iodotyrosines to iodothyronine residues in thyroglobulin (Tg) under oxidative conditions. The human TPO gene, which localizes on chromosome 2p25, is divided into 17 exons and covers approximately 150 kilobases (kb) of DNA. Differently sized TPO mRNAs have been recognized in thyroid cells. TPO defects are among the most-frequent cause of inborn abnormalities of thyroid hormone synthesis. Nearly 50 different mutations have been described, mostly single nucleotide substitutions and, in the minority, small deletions/insertions or splicing site mutations. Patients harboring TPO mutations, in compound heterozygosity or homozygosity, present with a TIOD, due to the impaired TPO function, resulting in CH. According to the recessive mode of inheritance, affected subjects are homozygous or compound heterozygous for gene mutations. However, about 20{\%} of the reported families with a TIOD phenotype harbor a single TPO mutated allele. The explanation for TIOD in these single heterozygous cases is presently unknown, except for three cases. The etiological diagnosis of CH, including dyshormonogenic defects due to TPO mutations, is based on clinical examination, biochemical tests, thyroid ultrasound and scintigraphy with KClO4 discharge test. Finally, the severe hypothyroidism resulting from TPO mutations should be promptly treated with the thyroid hormone, in order to maintain TSH levels at the lower limit of the normal range.",
author = "Laura Fugazzola",
year = "2009",
doi = "10.1016/B978-0-12-374135-6.00056-X",
language = "English",
isbn = "9780123741356",
pages = "539--547",
booktitle = "Comprehensive Handbook of Iodine",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Thyroid Peroxidase Deficiency and Total Iodide Organification Defect

AU - Fugazzola, Laura

PY - 2009

Y1 - 2009

N2 - The iodination of tyrosine residues or iodide organification, is catalyzed by the thyroperoxidase (TPO). TPO is a membrane-bound hemoprotein located at the apical membrane of the thyroid cell. Besides the binding of iodine to tyrosine, TPO also catalyzes the coupling of iodotyrosines to iodothyronine residues in thyroglobulin (Tg) under oxidative conditions. The human TPO gene, which localizes on chromosome 2p25, is divided into 17 exons and covers approximately 150 kilobases (kb) of DNA. Differently sized TPO mRNAs have been recognized in thyroid cells. TPO defects are among the most-frequent cause of inborn abnormalities of thyroid hormone synthesis. Nearly 50 different mutations have been described, mostly single nucleotide substitutions and, in the minority, small deletions/insertions or splicing site mutations. Patients harboring TPO mutations, in compound heterozygosity or homozygosity, present with a TIOD, due to the impaired TPO function, resulting in CH. According to the recessive mode of inheritance, affected subjects are homozygous or compound heterozygous for gene mutations. However, about 20% of the reported families with a TIOD phenotype harbor a single TPO mutated allele. The explanation for TIOD in these single heterozygous cases is presently unknown, except for three cases. The etiological diagnosis of CH, including dyshormonogenic defects due to TPO mutations, is based on clinical examination, biochemical tests, thyroid ultrasound and scintigraphy with KClO4 discharge test. Finally, the severe hypothyroidism resulting from TPO mutations should be promptly treated with the thyroid hormone, in order to maintain TSH levels at the lower limit of the normal range.

AB - The iodination of tyrosine residues or iodide organification, is catalyzed by the thyroperoxidase (TPO). TPO is a membrane-bound hemoprotein located at the apical membrane of the thyroid cell. Besides the binding of iodine to tyrosine, TPO also catalyzes the coupling of iodotyrosines to iodothyronine residues in thyroglobulin (Tg) under oxidative conditions. The human TPO gene, which localizes on chromosome 2p25, is divided into 17 exons and covers approximately 150 kilobases (kb) of DNA. Differently sized TPO mRNAs have been recognized in thyroid cells. TPO defects are among the most-frequent cause of inborn abnormalities of thyroid hormone synthesis. Nearly 50 different mutations have been described, mostly single nucleotide substitutions and, in the minority, small deletions/insertions or splicing site mutations. Patients harboring TPO mutations, in compound heterozygosity or homozygosity, present with a TIOD, due to the impaired TPO function, resulting in CH. According to the recessive mode of inheritance, affected subjects are homozygous or compound heterozygous for gene mutations. However, about 20% of the reported families with a TIOD phenotype harbor a single TPO mutated allele. The explanation for TIOD in these single heterozygous cases is presently unknown, except for three cases. The etiological diagnosis of CH, including dyshormonogenic defects due to TPO mutations, is based on clinical examination, biochemical tests, thyroid ultrasound and scintigraphy with KClO4 discharge test. Finally, the severe hypothyroidism resulting from TPO mutations should be promptly treated with the thyroid hormone, in order to maintain TSH levels at the lower limit of the normal range.

UR - http://www.scopus.com/inward/record.url?scp=84884452596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884452596&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374135-6.00056-X

DO - 10.1016/B978-0-12-374135-6.00056-X

M3 - Chapter

AN - SCOPUS:84884452596

SN - 9780123741356

SP - 539

EP - 547

BT - Comprehensive Handbook of Iodine

PB - Elsevier Inc.

ER -